Palatin Technologies (PINK:PTNT) Stock Crosses Above 200-Day Moving Average – Should You Sell?

Palatin Technologies, Inc. (PINK:PTNT)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.58 and traded as high as $7.00. Palatin Technologies shares last traded at $5.60, with a volume of 7,665 shares changing hands.

Palatin Technologies Price Performance

The firm has a market capitalization of $145.66 million, a PE ratio of -3.61 and a beta of 0.87. The stock’s 50-day moving average price is $5.60 and its 200 day moving average price is $5.58.

About Palatin Technologies

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy.